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BY INTRAVENOUS INJECTION OF DINITROBENZENE SULFONATE IN
GUINEA PIGS SENSITIZED TO DINITROCHLOROBENZENE*
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To influence the state of hypersensitivity in
contact-type sensitization, two kinds of ap-
proaches have been followed: on one hand, al-
ready sensitized individuals were treated with
the causal agent, in an attempt to diminish or
abolish their enhanced reactivity; on the other,
normal individuals were pretreated with the
causal agent in order to prevent them from
reacting to a subsequent sensitizing contact with
the same substance.
The first of these technics ("specific desensitiza-
tion") was used as early as in 1895 by J.
Jadassohn, when he postulated, even before
Richet's and von Pirquet's fundamental dis-
coveries, that sensitization could be the basic
mechanism of eczcmatous dermatitis due to
external agents. Desensitization of individuals
with contact dermatitis due to drugs has been
performed with variable results by progressive
systemic or local application of the drug (20, 26,
35). It has been claimed too (22, 21, 32, 5) that
in cases of occupational dermatitis, desensitiza-
tion may occur by repeated re-exposure to the
causative agent.
In animals sensitized experimentally to DNCB,
benzylchloride and picrylchloride, Landsteiner
and Jacobs (30) could show, that by repeated
subcutaneous injection of a conjugate of these
compounds with guinea pig serum, the con-
comitantly existing sensitivity of the immediate
type disappeared, but not the contact sensitivity
of the delayed type. W. Jadassohn and co-
workers (27, 24, 25) could considerably reduce
the level of sensitivity of guinea pigs previously
sensitized to DNCB by the daily application of
this compound on the animal's nipple for 150
consecutive days.
In hypersensitivity of plant origin, desensitiza-
tion has been extensively tried with variable
results. This subject which has been inaugurated
by McNair (33) and Shelmire (38) has recently
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been revised by Kligman (28, 29) who concludes
that a partial and temporary hyposensitization
may be achieved after oral or intramuscular ad-
ministration of the allergen for 5 to 9 months but
that severe systemic and local reactions occur,
when the allergen is given during the acute phase
of the dermatitis.
In experiments with guinea pigs Stratton (40,
41) obtained a certain "skin protection" for at
least six months after giving whole extracts of
poison oak subcutaneously, intramuscularly or
orally.
The other approach, i.e. the pretrcating of
normal individuals with the causative agent in
order to prevent subsequent sensitization was
first carried out by Sulzberger (42). In his re-
markable experiments, in which the studies of
W. Frei (13, 14) were confirmed and continued,
one of the projected aims (desensitization of
animals previously sensitized to arsphcnamine
by an intracardial injection of a high dose of this
drug administered 14 days later) was not
achieved, but sensitization was prevented, when
the intracardial injection was given 24 hours
after the sensitizing contact. This sequence of
events, which theoretically would not have been
expected, seems to be characteristic for arsphen-
amine and does not occur, as will be shown, with
other chemical compounds.
Experiments designed to prevent sensitization
to simple chemical compounds seem not to have
been pursued until 1943, when Chase (6) by "a
fortunate rediscovery" demonstrated that feed-
ing the allergenic chemical (DNCB) prior to
inducing sensitization, resulted in only weak skin
test reactions, and some animals were entirely
unresponsive (7, 8).
Similar results were obtained by Baer and co-
workers (1, 2) with feeding pregnant guinea pigs
DNCB or picryl chloride and subsequently sen-
sitizing their offspring. Later, this group of in-
vestigators (23) could obtain a significant reduc-
tion of the susceptibility to sensitization to
DNCB in the offspring of guinea pigs which were
intraperitoneally injected with DNCB during
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pregnancy. This actively acquired tolerance ap-
peared to be specific since it did not extend to
citraconic anhydride, as immunologically un-
related compound.
Still unresolved is the question of whether the
type of experiments commonly designated as
"desensitization" and those envisaging unrespon-
siveness (which may be closely related to what is
called Immuno-Paralysis and Immuno-Toler-
ance) are based on a similar immunologic
mechanism (9, 36).
In previous experiments (16) attempting de-
sensitization, we have observed in guinea pigs
sensitized to DNCB a not reproducible lowering
of the level of sensitivity after massive epicutane-
ous contacts with the compound on extensive
skin areas.
Recently (17) we demonstrated that the
contact type of hypersensitivity of guinea pigs
to DNCB, as manifested by the epicutaneous
test, can be partially and specifically inhibited
by an injection of DNCB given in a vein of the
hind leg 6 hours before performing the challeng-
ing test. This inhibitory effect was temporary,
and the animals regained their original level of
sensitivity a few days after the injection.
In the present paper, experiments are described
in which not only a partial but also complete
inhibition of the hypersensitivity was obtained
in one third of the animals injected intravenously
with the immunologically related sodium dinitro-
benzenesulfonate (DNBSO3). The greager solu-
bility and lower toxicity of this substance made
possible the administration of larger amounts
than DNCB.
MATERIALS AND METHODS
Reagent grade 2:4 dinitro-1-chlorobenzene(DNCB) from Merck, Darmstadt; 2:4 dinitro-
benzenesulforiic acid sodium salt (DNBSO3) from
Eastman Kodak, Rochester, N.Y. and a-2-chlor-
9-(3-dimethyl-aminopropylidefle) thioxanthene hy-
drochloride, chiorprothixene hydrochloride (CPT)
from Hoffmann-La Roche Inc. Base!.
Freund's adjuvant was prepared according to
the original procedure (15).
White semi-inbred guinea pigs of both sexes
weighing 400—500 gm were used throughout.
Sensitization Technic
a) DNCB: Most of the animals were sensitized
by one single epicutaneous application of 0.002
ml of a 50% solution in acetone (total amount
0.001 gm) on a skin area of 0.5 cm2 located on the
neck. By such a procedure nearly 100% of the
animals become sensitized (18, 19).
Some groups of animals were sensitized by intra-
dermal injection in the neck of 0.1 ml of Freund's
adjuvant, containing 0.05% DNCB, given on 3
alternate days (total amount of DNCB = 150 ag).
b) DNBSO3: Intradermal injection of 0.1 ml of a
20% aqueous solution, given on 3 alternate days(total amount = 0.06 g).
c) CPT: Intradermal injection of 3 )< 0.1 ml of a
20% aqueous solution given on alternate days(total amount = 0.06 g).
d) Some animals were injected simultaneously
with DNCB and CPT given in Freund's adjuvant
in order to obtain sensitization to both immuno-
logically unrelated substances on the same animal.
0.1 ml of Freund's adjuvant containing 0.05%
DNCB and 10% CPT was injected intradermally
on 3 alternate days.
Skin Testing
DNCB: The tests were performed by epicu-
taneous application with the aid of a micropipette
on the flank of 0.025 ml of 0.09, 0.05 and 0.03 per
cent solutions of DNCB in acetone over three skin
areas of 2 cm'. The total amounts of DNCB ap-
plied were 22.5, 12.5 and 7.5 jig.
These and the other test solutions described
below are primarily non-irritating.
DNBSO,: Epicutaneous application of 0.025 ml
of 20, 6 and 2 per cent aqueous solutions as de-
scribed above (total amounts 5 mg, 1.5 mg and
0.5 mg respectively). The reactions were stronger
when the test solutions contained 10% "Emul-
gen* or 2% lauryl sulfate as wetting agents.
CPT: Epicutaneous application of 0.025 ml of
aqueous solutions of 10, 3 and 1 per cent. (Total
amounts 2.5 mg, 0.75mg and 0.25mg respectively.)
The test reactions were read 24 hours after ap-
plication of the solution. Their intensity was
evaluated as follows:
0.5: isolated red spots
1: diffuse slight redness
2: marked redness and slight swelling
3: deep redness and considerable swelling
The sum of the readings obtained with the three
different test concentrations of each drug gives
some numerical estimate of the hypersensitivity
level of the animal tested which may be used to
determine the average sensitivity of a group of
animals. Details of the method of testing and its
quantitative evaluation have been published else-
where (18, 19). Animals sensitized by one single
application of DNCB have a relatively low sensi-
tivity level (3.4 to 2.8) whereas animals sensitized
by injection of DNCB and Freund's adjuvant
exhibit a higher sensitivity level (6.6 to 3.8).
Inhibition of Contact Reaction
Fourteen days after the sensitizing application(or injection) the animals were tested in order to
evaluate their hypersensitivity level and the tests
read and evaluated on the 15th day (first or "refer-
ence test"). On the 17th day after sensitization,
* Octaethyleneglycol monodecylether.
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the animals were injected intravenously with
DNBSO3 solutinn. Six hours later they were tested
again in the usual way (second or "challenge
test"). Additional skin tests were performed 1, 5
and 12 days after the intravenous injection.
DNBSO, was given in doses of 500 and 1000
mg/kg in a vein of the hind leg (injection of 2 or
4 ml/kg respectively of a 25% aqueous solution).
Under short ether anesthesia the skin covering
the vein was incised, the vein penetrated directly
with the needle and the incision closed with Michel
clamps.
Controls
The following groups of control animals were
set up, the guinea pigs being sensitized and tested
in the same way as were the group receiving intra-
venous DNBSO3:
a) Intravenous saline injection + anesthesia +
skin incision
b) Anesthesia + skin incision
c) Skin testing only ("positive controls" not
mentioned in our figures).
Other groups were not sensitized hut had:
d) Skin testing only ("negative controls")
e) Intravenous DNBSO2 injection + skin
testing.
Control groups a) and b) would show the part
played by the liquid injected and by the operative
trauma. Group c) would show the influence of re-
peated skin testing on the sensitivity level. Group
d) and e) should show the effect of repeated skin
testing and intravenous injection of DNBSO3
on the hypersensitivity level of normal animals.
EXPERIMENTS AND RESULTS
1) Cross-reactions between DNCB and DNBSO3
In order to demonstrate the immunologic rela-
tionship between DNCB and DNJISO3, various
TABLE 1
Animals Tested with:
AnimalsSensitized with: DNCB DNa so,
Tests Total no.
positive of animals
Tests
positive
Total no.
of animals
DNCB
DNBSO3
44
23
44
24
26
7
5
6
20
S
32*
7t
St
16
20t
St
* DNBSO2 in aqueous solution.
t DNBSO, in aqueous solution + Emulgen or
lauryl sulfate.
al i._°ft_—"\. _—
days
bI :Fct1s1
days
cl:, 2animaa
days
068603 iv
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Fm. 1. Inhibition of the contact reaction to
DNCB by intravenous injection of DNBSO, in
guinea pigs sensitized by epicutaneous applica-
tion of DNCB. Course of the average sensitivity
level in a) guinea pigs sensitized by one applica-
tion of DNCB on the neck. First series of tests
after 14 days. Intravenous injection of 500 ing/kg
DNBSO, in saline on the 16th day. Application of
the challenge tests 6 hours after the intravenous
injection. Further series of tests at later intervals.
b) control group of sensitized guinea pigs tested
at same intervals but receiving intravenous injec-
tion of saline alone. c) control group of sensitized
guinea pigs tested at same intervals but receiving
only anesthesia and skin incision. d) control group
of non-sensitized guinea pigs tested at same inter-
vals and receiving 500 mg/kg DNBSO3 intra-
venously on the 16th day. e) control group of non-
sensitized guinea pigs tested at same intervals.
groups of guinea pigs were sensitized and tested
with one or the other compound. As shown in
Table I, positive skin tests could be elicited with
both substances, regardless of which one had been
used for the sensitization. Higher proportions of
positive tests with DNBSO2 were obtained with
aqueous solutions of the same concentration
when wetting agents were added, as already re-
ported by Eisen et al. (10).
2) Inhibitory Effect of DNBS'O3 (Fig. 1, Table 2)
According to the technic described above, 59
guinea pigs were sensitized against DNCB,
tested after 14 days in order to determine their
10
10
0
Cross reactions between DNCB and DP'/BSO:i
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TABLE 2
Inhibition of the contact reaction to DNCB by intravenous injection of DNBSOS in guinea pigs
sensitized by epicutaneous application of DNCB
Intensity of the reactions to the challenge test
Experiment Animals
Intensity of the Reactions (Sensitivity Level)
0 <1 <2 <3 3
500 mg/kg DNBSO3 iv.
2 mi/kg saline i.v.
Anesthesia + skin incision only
59
100%
66
100%
62
100%
20
34%
0
0%
0
0%
24
41%
1
1%
2
3%
13
22%
12
18%
15
24%
2
3%
34
52%
28
45%
0
0%
19
29%
17
28%
Challenge test applied 6 hours after the intravenous injection. The intensity of the reactions repre-
sents the average value of the 3 tests per animal of each group (see Materials and Methods).
sensitivity level ("reference test") and injected
intravenously with DNBSO3 at the dose of 500
mg/kg one day later. Six hours after the injec-
tion, they were tested with DNCB for the second
time ("challenge test"), this test being read 24
hours later. Upon injection of DNBSO3, the
hypersensitivity level of the animals to DNCB
was markedly decreased, as shown by comparing
the intensity of the reactions observed in the same
animals to the same test concentrations before
and after the injection.
In our previous experiments using DNCB as an
inhibitory agent, only some diminution of the
hypersensitivity level was obtained (17). In the
present experiments with DNBSO3, approxi-
mately of the 59 animals showed complete
inhibition, the challenge tests being negative with
all concentrations used. Another j!4 showed
partial but marked inhibition, the challenge
reactions being weaker than degree 1. This con-
trasts strikingly with the two control groups d)
and e) of 66 and 62 animals, where no negative
reactions were found, of them showing reac-
tions of degree 3 or stronger. In animals not
sensitized previously to DNCB, the intravenous
injection of DNBSO3 did not seem to induce
sensitivity.
3) Specificity of Inhibition (Fig. 2)
Ten animals (group a) were sensitized simul-
taneously to DNCB and to CPT, and were sub-
sequently injected with 500 mg/kg of DNBSO3.
A control group (b) was sensitized in the same
way but was submitted only to anesthesia, skin
incision and saline injection. A third group (c)
was equally sensitized receiving anesthesia only.
Groups (d) and (e) were sensitized to DNCB or
CPT only (positive controls). Group (f) was
sensitized to CPT and injected with DNBSO3,
and finally group (g) was not sensitized but re-
ceived DNBSO3.
In the ten double-sensitized animals injected
with 500 mg/kg DNBSO3, the challenge test with
DNCB was partially inhibited, the sensitivity
level against CPT remaining practically unim-
paired. The injection of DNBSO3 in animals
sensitized to CPT only did flot reduce signifi-
cantly their sensitivity level to CPT.
Previous experiments on animals similarly
double-sensitized or sensitized to CPT only,
which received an intravenous injection of DNCB
already demonstrated the specificity of the in-
hibitory effect (17).
4) Flare-up Reactions (Fig. 3, Table 3)
In the same group of animals mentioned
under 2), it was observed that the reference test
became distinctly stronger 48 hours and 72 hours
after the injection of DNBSO3. This occurred
concomitantly with the inhibitory effect on the
challenge test, performed 6 hours after the
intravenous injection. This flare-up reaction
could be observed in 32 out of the 59 animals
receiving DNBSO3, the remaining 27 animals of
the group having not been followed up in this
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FIG. 2. Specificity of the inhibitory effect of
intravenously injected DNBSO3 on the contact
reaction to DNCB. Course of the average sensi-
tivity level to DNCB and CPT in: a) guinea pigs
double-sensitized by one application of DNCB and
three injections of CPT. Intravenous injection of
500 mg/kg DNBSO3 in saline. b) control group of
double-sensitized animals injected with saline
only. c) control-group of double-sensitized animals
received only anesthesia and skin incision. d)
control group of animals sensitized to DNCB
only. e) control group of animals sensitized to
CPT only. f) control group of animals sensitized
to CPT only. Intravenous injection of 500 mg/kg
DNBSO3 in saline. g) control group of non-
sensitized animals tested at same intervals and
receiving 500 mg/kg DNBSO1 intravenously on
the 10th day.
respect. In control animals, the reference test
presented the normal vanishing course.
5) Generalized Dermatitis
In two groups of animals, the intravenous in-
jection of DNBSO3 elicited a generalized derma-
titis, characterized by an erythematous rash in-
volving the whole skin. The erythema was
clearly apparent on the shaved flanks and on the
glabrous skin of the ears; it could be recognized
also on intact skin through the fur. The erythema
appeared 5 hours after the injection of DNBSO3
and could well be recognized after 24 hours. At
the onset, it was diffuse and later became ir-
regular (roseoliform). A generalized scaling ap-
peared on the third day after the onset of the
dermatitis and lasted for several days. On the
diffusely erythematous skin, the reference tests
were readily observed as more erythematous and
swollen areas. The evaluation of the challenge
tests, however, was sometimes made difficult
by the erythematous background.
3 days The generalized dermatitis was observed quite
regularly in a first group of 6 animals which had
been sensitized by intradermal injection of DNCB
in Freund's adjuvant and which received an intra-
days venous injection of 500 mg/kg of DNBSO3.
These animals had a high sensitivity level (5.3) to
start with. On the other hand, animals sensitized
days by epicutaneous application of DNCB alone and
41 animals
'1
20 30 days
F'u. 3. Flare-up of older test sites in guinea
pigs sensitized to DNCB and intravenously in-jected with DNBSO3. Readings on three successive
days of the reference test applied before the i.v.
injection, the challenge test applied six hours after
the i.v. injection, and of the additional tests. a)
guinea pigs sensitized to DNCB by epicutaneous
application and injected intravenously with 500
mg/kg DNBSO3 in saline. b) and c) guinea pigs
sensitized in the same way but submitted to
saline injection or anesthesia and skin incision
only.
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TABLE 3
Flare-up of older test sites after intravenous injection of DNB,803 in guinea pigs sensitized by epicutaneous
application of DNCB
Intensity of the reactions to the reference test
Experiment No. of Animals
32
41
38
Intensity of the Reactions
(Sensitivity Level)
Hours altec application of the teat
24 48 72
Hours after iv. injection
— 0
2.9 3.5
2.8 2.5
2.8 2.6
30
4.0
2.2
2.4
500 mg/kg, DNBSO3 i.v
2m1/kgsalinei.v
Anesthesia+skinincisiononly
Intensity of the reactions expressed as the average of the sum of the readings at various intervals
after application of the reference tests (see Materials and Methods). In most animals of the first group
(i.v. injection of DNBSO3), the second series of tests (challenge test) gives negative or very low readings
(see Fig. 1, Table 2).
demonstrating a lower sensitivity level, as well as
non-sensitized animals, did not show any gen-
eralized rash upon intravenous injection of the
same dose (500 mg/kg) of DNBSO3.
In a second group of 6 animals sensitized by
the usual epieutaneous application of DNCB and
demonstrating a low sensitivity level (3.8), the
intravenous injection of the high dose of 1000
mg/kg of DNBSO3 could elicit a similar derma-
titis in 3 animals, 2 dying shortly after the
injection (1000 mg/kg is about the LD5O%)
and 1 showing no dermatitis but complete in-
hibition of the challenge tests.
These preliminary results seem to indicate that
the generalized dermatitis can be induced in
highly sensitized animals with relatively low
doses of DNBSO3 whereas lesser sensitized
guinea pigs will require higher doses. The patho-
logical and microscopic findings accompanying
the appearance of the erythematous rash have
not yet been evaluated.
nIsCUssION
The results of our experiments demonstrate
that in guinea pigs with contact hypersensitivity
to DNCB, a complete although temporary in-
hibition of the contact reaction can be achieved
by an intravenous injection of DNBSO3. In fact
in j of the animals, the challenge test became
negative, another j showing definitely weaker
reactions as compared with the controls. In our
previous experiments, when DNCB was used for
intravenous injection, no complete inhibition,
but only a diminution of the test reactions was
obtained. This difference might be due to the
fact that DNBSO3, because of its lower toxicity,
could be given in doses of 500 and 1000 mg/kg
whereas DNCB in doses larger than 10 mg/kg
was not tolerated.
The inhibition obtained may be considered
specific, i.e. not due to an impairment of the
organism's general reactivity, since the hyper-
sensitivity against another unrelated hapten
(CPT) was not influenced by the intravenous
injection of the DNBSO3.
Because the inhibitory effect demonstrated by
DNCB and DNBSO3 is specific, it should be
possible to determine whether the inhibition is
due to the injected compounds acting as uni-
functional haptens or to dinitrophenyl conjugates
formed in vivo. It is well known, since the classical
experiments of Landsteiner, that the precipita-
tion of circulating anti-hapten antibodies by
the corresponding hapten-protein conjugates
may be specifically inhibited by an excess of uni-
functional hapten, blocking the antibody's com-
bining sites and forming soluble hapten-antibody
complexes. A similar mechanism may explain
the specific inhibition of immediate type allergic
reactions, such as anaphylaetie shock (31),
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passive cutaneous anaphylaxis (34) and wheal-
and-erythema reactions (11) by unifunctional
haptens. It is quite clear that, in the case of the
delayed type contact reaction, we are faced with
a very different situation. Preliminary experi-
ments, which will be reported elsewhere (43),
suggest that the inhibitory effect of intravenously
injected DNCB and DNBSO3 on the contact
reaction to DNCB is not due to the compounds
acting as haptens but to the dinitrophenyl protein
conjugates formed in vivo.
On the other hand, the fact that the intra-
venous injection of DNBSO3 causes both an
inhibition of the contact reaction and a flare-up
of old test sites might at first glance seem para-
doxical. Similarly, the fact that there is some
relationship between the level of sensitivity of an
animal and the outcome (inhibition or gen-
eralized dermatitis) of an intravenous injection
of a given dose of DNBSO1 make it probable that
some quantitative aspects may be involved in
the mechanisms of this phenomenon as well as
in the contact reaction.
Finally our experiments arc consistent with the
results obtained by Sulzbcrgcr (42) in guinea pigs
sensitized to arsphenamine in which an intra-
cardial injection of the sensitizing compound
provoked a flare-up of the site of sensitization or
the site of previous—actually evanishcd—test.
We could further confirm Sulzberger's observa-
tion, that in some of his animals, the intracardial
injection of the compound elicited a generalized
dermatitis, a phenomenon we arc noting now
after intravenous injections of DNBSO3 in ap-
proximately j of our animals so treated. Such an
exacerbation and generalization of localized
eczematous dermatitis after a subsequent oral or
parenteral supply of antigen has been often de-
scribed in the human (37, 3, 44, 12, 4, 39). We
will consider later Sulzbergcr's findings concern-
ing the state of unresponsiveness obtained with
an intracardial injection of arsphenaminc given
24 hours after the sensitizing intradermal
injection.
SUMMARY
Guinea pigs with contact hypersensitivity to
dinitrochlorobenzcne (DNCB) were injected
intravenously with dinitrobenzene sulfonic acid
sodium salt (DNBSO3) six hours before perform-
ing an epicutancous test with DNCB. In one
third of these animals, the reactivity, as shown
by an epicutaneous test, could be completely
inhibited for some days. The inhibition was
specific as evidenced by the unchanged reactivity
to an other, immunologically unrelated sub-
stance, to which the same animals were sensitized
concomitantly.
Coincident with the inhibitory effect on the
challenging test, the intravenous injection of
DNBSO3 brought about, in some animals, a
flare-up of older test sites.
In highly sensitized animals and in instances
of large dosage, the intravenous injection of
DNBSO3 elicited a generalized dermatitis.
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